Bharat Immunolog

9
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE994B01014
  • NSEID:
  • BSEID: 524663
INR
19.38
-0.77 (-3.82%)
BSENSE

Feb 09

BSE+NSE Vol: 46.9 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2023 is -43.09% vs -8.14% in Mar 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2023 is -270.44% vs 76.12% in Mar 2022

stock-summary

Interest

YoY Growth in year ended Mar 2023 is 25.92% vs 17.04% in Mar 2022

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2023 is -94.85% vs 51.67% in Mar 2022

Compare Profit and Loss Results of Bharat Immunolog
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
44.00
114.00
-70.00
-61.40%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
44.00
114.00
-70.00
-61.40%
Expenditure (Ex Depriciation)
Stock Adjustments
5.00
0.00
5.00
0%
Raw Materials Consumed
33.00
97.00
-64.00
-65.98%
Power & Fuel Cost
1.00
0.00
1.00
0%
Employee Cost
15.00
2.00
13.00
650.00%
Operating Expenses
3.00
0.00
3.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
6.00
-6.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
63.00
111.00
-48.00
-43.24%
Operating Profit (PBDIT) excl Other Income
-18.00
3.00
-21.00
-700.00%
Other Income
2.00
2.00
0.00
0.00%
Operating Profit (PBDIT)
-15.00
5.00
-20.00
-400.00%
Interest
7.00
0.00
7.00
0%
Profit before Depriciation and Tax
-22.00
5.00
-27.00
-540.00%
Depreciation
0.00
1.00
-1.00
-100.00%
Profit Before Taxation & Exceptional Items
-22.00
4.00
-26.00
-650.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-22.00
4.00
-26.00
-650.00%
Provision for Tax
-5.00
0.00
-5.00
0%
Profit After Tax
-17.00
3.00
-20.00
-666.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-49.00
8.00
-57.00
-712.50%
Profit Available for appropriations
-66.00
12.00
-78.00
-650.00%
Appropriations
-66.00
12.00
-78.00
-650.00%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-3.95
0.2
-4.15
-2,075.00%
Profit And Loss - Net Sales
Net Sales 44.61 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -43.09% vs -8.14% in Mar 2022

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -18.47 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -270.44% vs 76.12% in Mar 2022

Profit And Loss - Interest
Interest 7.04 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is 25.92% vs 17.04% in Mar 2022

Profit And Loss - Profit After Tax
Profit After Tax -17.06 Cr
in Mar 2023

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2023 is -94.85% vs 51.67% in Mar 2022